<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    <title>New Research Finds Potential Alternative to Abortion Pill Mifepristone | Khanh's feed</title>
    <link
      rel="stylesheet"
      type="text/css"
      href="../styles.css"
      media="screen"
    />
  </head>
  <body>
    <a href="/index.html">Back</a>
    <a href="https://www.nytimes.com/2025/01/23/health/abortion-pill-ella.html">Original</a>
    <h1>New Research Finds Potential Alternative to Abortion Pill Mifepristone</h1>
    
    <div id="readability-page-1" class="page"><div id="site-content"><div><div id="in-story-masthead"><div><p><span><a href="https://www.nytimes.com/section/health">Health</a></span><span>|</span><span>New Research Finds Potential Alternative to Abortion Pill Mifepristone</span></p><div><p><span>https://www.nytimes.com/2025/01/23/health/abortion-pill-ella.html</span></p></div></div></div><article id="story"><div aria-live="polite"><p>You have a preview view of this article while we are checking your access. When we have confirmed access, the full article content will load.</p></div><header><p id="article-summary">The research could further complicate the polarized politics of abortion because the drug in the study is the key ingredient in a pill used for emergency contraception.</p><div data-testid="imageblock-wrapper"><figure aria-label="media" role="group"><div data-testid="imageContainer-children-Image"><picture><source media="(max-width: 599px) and (min-device-pixel-ratio: 3),(max-width: 599px) and (min-resolution: 3dppx),(max-width: 599px) and (min-resolution: 288dpi)" srcset="https://static01.nyt.com/images/2025/01/22/multimedia/00AbortionMorningAfterPill-01-jklq/00AbortionMorningAfterPill-01-jklq-mobileMasterAt3x.jpg?quality=75&amp;auto=webp&amp;disable=upscale&amp;width=1800"/><source media="(max-width: 599px) and (min-device-pixel-ratio: 2),(max-width: 599px) and (min-resolution: 2dppx),(max-width: 599px) and (min-resolution: 192dpi)" srcset="https://static01.nyt.com/images/2025/01/22/multimedia/00AbortionMorningAfterPill-01-jklq/00AbortionMorningAfterPill-01-jklq-mobileMasterAt3x.jpg?quality=75&amp;auto=webp&amp;disable=upscale&amp;width=1200"/><source media="(max-width: 599px) and (min-device-pixel-ratio: 1),(max-width: 599px) and (min-resolution: 1dppx),(max-width: 599px) and (min-resolution: 96dpi)" srcset="https://static01.nyt.com/images/2025/01/22/multimedia/00AbortionMorningAfterPill-01-jklq/00AbortionMorningAfterPill-01-jklq-mobileMasterAt3x.jpg?quality=75&amp;auto=webp&amp;disable=upscale&amp;width=600"/><img alt="A close-up view of an open palm with a single pill in its center hovering over a bathroom counter with a pill packet on top." src="https://static01.nyt.com/images/2025/01/22/multimedia/00AbortionMorningAfterPill-01-jklq/00AbortionMorningAfterPill-01-jklq-articleLarge.jpg?quality=75&amp;auto=webp&amp;disable=upscale" srcset="https://static01.nyt.com/images/2025/01/22/multimedia/00AbortionMorningAfterPill-01-jklq/00AbortionMorningAfterPill-01-jklq-articleLarge.jpg?quality=75&amp;auto=webp 600w,https://static01.nyt.com/images/2025/01/22/multimedia/00AbortionMorningAfterPill-01-jklq/00AbortionMorningAfterPill-01-jklq-jumbo.jpg?quality=75&amp;auto=webp 1024w,https://static01.nyt.com/images/2025/01/22/multimedia/00AbortionMorningAfterPill-01-jklq/00AbortionMorningAfterPill-01-jklq-superJumbo.jpg?quality=75&amp;auto=webp 2048w" sizes="((min-width: 600px) and (max-width: 1004px)) 84vw, (min-width: 1005px) 60vw, 100vw" decoding="async" width="600" height="400"/></picture></div><figcaption data-testid="photoviewer-children-ImageCaption"><span>Mifepristone is the first pill in the typical two-drug medication abortion regimen. A study found a potential substitute for mifepristone, which has been targeted by abortion opponents.</span><span><span>Credit...</span><span><span aria-hidden="false">Adria Malcolm for The New York Times</span></span></span></figcaption></figure></div><p><time datetime="2025-01-23T13:00:07-05:00"><span>Jan. 23, 2025</span></time></p></header><section name="articleBody"><div data-testid="companionColumn-0"><div><p>A <a href="https://evidence.nejm.org/doi/full/10.1056/EVIDoa2400209" title="" rel="noopener noreferrer" target="_blank">new study</a> suggests a possible alternative to the abortion pill mifepristone, a drug that continues to be a target of lawsuits and legislation from abortion opponents.</p><p>But the potential substitute could further complicate the politics of reproductive health because it is also the key ingredient in a contraceptive morning-after pill.</p><p>The new study, <a href="https://evidence.nejm.org/doi/full/10.1056/EVIDoa2400209" title="" rel="noopener noreferrer" target="_blank">published Thursday in the journal NEJM Evidence</a>, involved a drug called ulipristal acetate, the active ingredient in the prescription contraceptive Ella, one of two types of morning-after pills approved in the United States. (The other, Plan B One-Step, which does not require a prescription, contains a different drug and does not work in a way that would terminate a pregnancy, according to scientific evidence.)</p><p>In the study, 133 women who were up to nine weeks’ pregnant took twice the dose of the ulipristal acetate contained in Ella, followed by misoprostol, the second drug used in the typical medication abortion regimen. All but four of the women completed the termination of their pregnancies without further intervention, a 97 percent completion rate that is similar to the regimen using mifepristone. (The others finished the process with additional medication or a procedure.)</p></div></div><div data-testid="companionColumn-1"><div><p>There were no serious complications, and the study concluded that using ulipristal acetate in the two-drug medication abortion regimen was safe.</p><p>Dr. Beverly Winikoff, the lead author of the study and the president of Gynuity Health Projects, a reproductive health research organization, said that after the Supreme Court overturned the national right to abortion in 2022, she became increasingly interested in a possible role for ulipristal acetate, which has a similar chemical structure to mifepristone.</p><div><div><div><div id="optimistic-truncator-a11y" tabindex="-1"><hr/><p>Thank you for your patience while we verify access. If you are in Reader mode please exit and <a href="https://myaccount.nytimes.com/auth/login?response_type=cookie&amp;client_id=vi&amp;redirect_uri=https%3A%2F%2Fwww.nytimes.com%2F2025%2F01%2F23%2Fhealth%2Fabortion-pill-ella.html&amp;asset=opttrunc">log into</a> your Times account, or <a href="https://www.nytimes.com/subscription?campaignId=89WYR&amp;redirect_uri=https%3A%2F%2Fwww.nytimes.com%2F2025%2F01%2F23%2Fhealth%2Fabortion-pill-ella.html">subscribe</a> for all of The Times.</p><hr/></div><div><svg width="24" height="24" viewBox="0 0 24 24" aria-hidden="true" data-testid="optimistic-truncator-spinner"><g fill="currentColor"><path d="M11.28 22.8a.72.72 0 1 0 1.44 0v-6.72a.72.72 0 1 0-1.44 0v6.72Z" opacity=".37"></path><path d="M17.766 21.16a.72.72 0 1 0 1.165-.846l-3.95-5.436a.72.72 0 1 0-1.165.846l3.95 5.437Z" opacity=".26"></path><path d="M1.506 14.653a.72.72 0 0 0 .445 1.37l6.391-2.078a.72.72 0 1 0-.445-1.369l-6.39 2.077Z" opacity=".61"></path><path d="M5.07 20.314a.72.72 0 0 0 1.164.847l3.95-5.437a.72.72 0 1 0-1.165-.846l-3.95 5.436Z" opacity=".48"></path><path d="M22.049 16.022a.72.72 0 0 0 .445-1.37l-6.391-2.076a.72.72 0 1 0-.445 1.37l6.39 2.076Z" opacity=".17"></path><path d="M22.494 9.347a.72.72 0 1 0-.445-1.37l-6.391 2.078a.72.72 0 1 0 .445 1.369l6.39-2.077Z" opacity=".09"></path><path d="M6.234 2.84a.72.72 0 0 0-1.165.846l3.95 5.436a.72.72 0 0 0 1.165-.846l-3.95-5.437Z" opacity=".87"></path><path d="M1.951 7.978a.72.72 0 1 0-.445 1.37l6.391 2.076a.72.72 0 1 0 .445-1.37l-6.39-2.076Z" opacity=".74"></path><path d="M18.93 3.686a.72.72 0 0 0-1.164-.847l-3.95 5.437a.72.72 0 0 0 1.165.846l3.95-5.436Z" opacity=".02"></path><path d="M12.72 1.2a.72.72 0 1 0-1.44 0v6.72a.72.72 0 0 0 1.44 0V1.2Z"></path></g></svg><div data-testid="optimistic-truncator-message"><p>Thank you for your patience while we verify access.</p><p>Already a subscriber? <a data-testid="log-in-link" href="https://myaccount.nytimes.com/auth/login?response_type=cookie&amp;client_id=vi&amp;redirect_uri=https%3A%2F%2Fwww.nytimes.com%2F2025%2F01%2F23%2Fhealth%2Fabortion-pill-ella.html&amp;asset=opttrunc">Log in</a>.</p><p>Want all of The Times? <a data-testid="subscribe-link" href="https://www.nytimes.com/subscription?campaignId=89WYR&amp;redirect_uri=https%3A%2F%2Fwww.nytimes.com%2F2025%2F01%2F23%2Fhealth%2Fabortion-pill-ella.html">Subscribe</a>.</p></div></div></div></div></div></div></div></section></article></div></div></div>
  </body>
</html>
